Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
62.3M
-
Number of holders
-
82
-
Total 13F shares, excl. options
-
36.9M
-
Shares change
-
-2.91M
-
Total reported value, excl. options
-
$329M
-
Value change
-
-$25.8M
-
Put/Call ratio
-
0.32
-
Number of buys
-
39
-
Number of sells
-
-27
-
Price
-
$8.91
Significant Holders of Aura Biosciences, Inc. - Common Stock, $0.00001 par value per share (AURA) as of Q3 2024
89 filings reported holding AURA - Aura Biosciences, Inc. - Common Stock, $0.00001 par value per share as of Q3 2024.
Aura Biosciences, Inc. - Common Stock, $0.00001 par value per share (AURA) has 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.9M shares
of 62.3M outstanding shares and own 59.2% of the company stock.
Largest 10 shareholders include Matrix Capital Management Company, LP (6.92M shares), EVENTIDE ASSET MANAGEMENT, LLC (5.8M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (4.88M shares), BlackRock, Inc. (3.16M shares), Medicxi Ventures Management (Jersey) Ltd (3.04M shares), VANGUARD GROUP INC (1.81M shares), FRANKLIN RESOURCES INC (1.67M shares), Nantahala Capital Management, LLC (1.27M shares), Long Focus Capital Management, LLC (1.13M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.01M shares).
This table shows the top 82 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.